NFE2L2 and renal cell carcinoma: This finding was consistent with the current knowledge that RCC belongs to the type of tumors in which the Nrf2 pathway was shown to be constitutively activated mainly by the loss of Keap1 functions that lead to Nrf2 nuclear accumulation and enhances the transcription of Phase II enzymes [4].